Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel

<b>Background/Objective:</b> Little information is available on the stability and quality controls of compounded 40% dextrose gel required to ensure its safe use in the treatment and prevention of neonatal hypoglycemia. Whether its efficacy relies on buccal absorption also remains uncert...

Full description

Saved in:
Bibliographic Details
Main Authors: Edouard Lamy, Caroline Orneto, Oumil Her Abdou Ali, Lyna Kireche, Fanny Mathias, Cyrielle Bouguergour, Florence Peyron, Nicolas Primas, Christophe Sauzet, Philippe Piccerelle, Anne-Marie Maillotte, Veronique Brevaut-Malaty, Pascal Rathelot, Patrice Vanelle, Christophe Curti
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/18/2/204
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850080135487684608
author Edouard Lamy
Caroline Orneto
Oumil Her Abdou Ali
Lyna Kireche
Fanny Mathias
Cyrielle Bouguergour
Florence Peyron
Nicolas Primas
Christophe Sauzet
Philippe Piccerelle
Anne-Marie Maillotte
Veronique Brevaut-Malaty
Pascal Rathelot
Patrice Vanelle
Christophe Curti
author_facet Edouard Lamy
Caroline Orneto
Oumil Her Abdou Ali
Lyna Kireche
Fanny Mathias
Cyrielle Bouguergour
Florence Peyron
Nicolas Primas
Christophe Sauzet
Philippe Piccerelle
Anne-Marie Maillotte
Veronique Brevaut-Malaty
Pascal Rathelot
Patrice Vanelle
Christophe Curti
author_sort Edouard Lamy
collection DOAJ
description <b>Background/Objective:</b> Little information is available on the stability and quality controls of compounded 40% dextrose gel required to ensure its safe use in the treatment and prevention of neonatal hypoglycemia. Whether its efficacy relies on buccal absorption also remains uncertain. This study investigates the stability, microbiological safety, rheological properties and dextrose diffusion of a compounded 40% oral dextrose gel, ensuring it can be widely compounded and stored for clinical use. <b>Methods:</b> A 40% dextrose gel compounded with anhydrous dextrose, carboxymethylcellulose, citric acid, sorbic acid and sterile water was subjected to quality control measures including a dextrose content assay, degradation product analysis, microbiological testing and preservative efficacy. Stability studies were conducted at refrigerated (4–8 °C) and ambient temperatures for 7 days and 3 months, respectively. Rheological properties were assessed, and dextrose permeation was measured through an artificial membrane model that mimics a biological membrane. <b>Results:</b> The compounded gel demonstrated stability for up to 7 days at ambient temperature and 90 days when refrigerated. The dextrose content remained within the acceptable range (90–110%) and microbiological tests confirmed compliance with safety standards. The gel exhibited the consistent rheological properties and shear-thinning behavior appropriate for oral mucosal administration. In vitro permeation studies showed no evidence of dextrose diffusion with a long lag time followed by a low steady-state permeation flux. <b>Conclusions:</b> This study validates the compounding process of a stable 40% oral dextrose gel formulation for neonatal hypoglycemia management, which meets quality control criteria and can be safely administered in clinical practice, offering a cost-effective and safe alternative for neonatal care.
format Article
id doaj-art-9a421d2a510e4a69a584c0cf239061b9
institution DOAJ
issn 1424-8247
language English
publishDate 2025-02-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj-art-9a421d2a510e4a69a584c0cf239061b92025-08-20T02:45:01ZengMDPI AGPharmaceuticals1424-82472025-02-0118220410.3390/ph18020204Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose GelEdouard Lamy0Caroline Orneto1Oumil Her Abdou Ali2Lyna Kireche3Fanny Mathias4Cyrielle Bouguergour5Florence Peyron6Nicolas Primas7Christophe Sauzet8Philippe Piccerelle9Anne-Marie Maillotte10Veronique Brevaut-Malaty11Pascal Rathelot12Patrice Vanelle13Christophe Curti14Service Central de la Qualité et de L’information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 13005 Marseille, FranceCNRS, IRD, IMBE, Avignon University, Aix Marseille University, 13397 Marseille, FranceService Central de la Qualité et de L’information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 13005 Marseille, FranceService Central de la Qualité et de L’information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 13005 Marseille, FranceCNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Equipe de Pharmaco-Chimie Radicalaire, Aix-Marseille University, 13015 Marseille, FrancePharmacy Department, Marseille Nord University Hospital Pharmacy, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, FrancePharmacy Department, Marseille Nord University Hospital Pharmacy, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, FranceService Central de la Qualité et de L’information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 13005 Marseille, FranceCNRS, IRD, IMBE, Avignon University, Aix Marseille University, 13397 Marseille, FranceCNRS, IRD, IMBE, Avignon University, Aix Marseille University, 13397 Marseille, FranceDepartment of Neonatology, Larchet University Hospital, 06200 Nice, FranceDepartment of Neonatology, Marseille Nord University Hospital, Assistance Publique-Hôpitaux de Marseille, 13015 Marseille, FranceService Central de la Qualité et de L’information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 13005 Marseille, FranceService Central de la Qualité et de L’information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 13005 Marseille, FranceService Central de la Qualité et de L’information Pharmaceutiques (SCQIP), Pharmacy Department, Assistance Publique-Hôpitaux de Marseille, 13005 Marseille, France<b>Background/Objective:</b> Little information is available on the stability and quality controls of compounded 40% dextrose gel required to ensure its safe use in the treatment and prevention of neonatal hypoglycemia. Whether its efficacy relies on buccal absorption also remains uncertain. This study investigates the stability, microbiological safety, rheological properties and dextrose diffusion of a compounded 40% oral dextrose gel, ensuring it can be widely compounded and stored for clinical use. <b>Methods:</b> A 40% dextrose gel compounded with anhydrous dextrose, carboxymethylcellulose, citric acid, sorbic acid and sterile water was subjected to quality control measures including a dextrose content assay, degradation product analysis, microbiological testing and preservative efficacy. Stability studies were conducted at refrigerated (4–8 °C) and ambient temperatures for 7 days and 3 months, respectively. Rheological properties were assessed, and dextrose permeation was measured through an artificial membrane model that mimics a biological membrane. <b>Results:</b> The compounded gel demonstrated stability for up to 7 days at ambient temperature and 90 days when refrigerated. The dextrose content remained within the acceptable range (90–110%) and microbiological tests confirmed compliance with safety standards. The gel exhibited the consistent rheological properties and shear-thinning behavior appropriate for oral mucosal administration. In vitro permeation studies showed no evidence of dextrose diffusion with a long lag time followed by a low steady-state permeation flux. <b>Conclusions:</b> This study validates the compounding process of a stable 40% oral dextrose gel formulation for neonatal hypoglycemia management, which meets quality control criteria and can be safely administered in clinical practice, offering a cost-effective and safe alternative for neonatal care.https://www.mdpi.com/1424-8247/18/2/204dextrosecompoundingstabilitydiffusionHPLCrheology
spellingShingle Edouard Lamy
Caroline Orneto
Oumil Her Abdou Ali
Lyna Kireche
Fanny Mathias
Cyrielle Bouguergour
Florence Peyron
Nicolas Primas
Christophe Sauzet
Philippe Piccerelle
Anne-Marie Maillotte
Veronique Brevaut-Malaty
Pascal Rathelot
Patrice Vanelle
Christophe Curti
Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel
Pharmaceuticals
dextrose
compounding
stability
diffusion
HPLC
rheology
title Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel
title_full Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel
title_fullStr Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel
title_full_unstemmed Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel
title_short Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel
title_sort formulation quality control and stability study of pediatric oral dextrose gel
topic dextrose
compounding
stability
diffusion
HPLC
rheology
url https://www.mdpi.com/1424-8247/18/2/204
work_keys_str_mv AT edouardlamy formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT carolineorneto formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT oumilherabdouali formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT lynakireche formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT fannymathias formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT cyriellebouguergour formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT florencepeyron formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT nicolasprimas formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT christophesauzet formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT philippepiccerelle formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT annemariemaillotte formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT veroniquebrevautmalaty formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT pascalrathelot formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT patricevanelle formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel
AT christophecurti formulationqualitycontrolandstabilitystudyofpediatricoraldextrosegel